Aquavit Pharmaceuticals Adds New Patent To Its High-Tech Medical Portfolio

New York, NEW YORK, September 1, 2017 Aquavit Pharmaceuticals, Inc. announced that the United States Patent and Trademark Office (USPTO) has issued a patent for Apollo Technology, System and Method for Personalized Injection Treatment (PITO-001: Patent # 9,675,519). This follows Aquavit’s European Patent (#EP2667965) issued by the European Patent Office (EPO) on July 27, 2016 and provides a global protection for the first of its kind smart compounding technology and its big d